02196.HK
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 16.20
+0.37%Next report
Analyst consensus
- Next report date
- Mar 29, 2027
- EPS estimate
- HKD 0.43
- Revenue estimate
- HKD 11.0B
Latest reported
- Last report date
- Aug 25, 2026
- EPS actual
- HKD 0.75
- EPS estimate
- HKD 0.35
- Revenue actual
- HKD 23.5B
- Revenue estimate
- HKD 12.0B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +111.5%
- Revenue beats (12Q)
- 1
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 29, 2027